Project HeMiLa – Prophylactic treatment of hemiplegic migraine with Lamotrigine

Basic data

Acronym:
HeMiLa
Title:
Prophylactic treatment of hemiplegic migraine with Lamotrigine
Duration:
26/06/2017 to 26/06/2019
Abstract / short description:
Aim of the study: to evaluate the efficacy of lamotrigine in the prophylactic treatment of hemiplegic migraine with a focus on attack frequency.

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Tübingen, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.